Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: Quest Diagnostics Invests in Structural Bioinformatics

NEW YORK, Dec 14 - Quest Diagnostics, a gene-based medical testing company, said Friday it had made an equity investment in Structural Bioinformatics, extending a relationship that began in 1999.

Terms of the transaction were not disclosed.

“SBI is a technology leader in the large-scale computational generation of protein structures and leads the field in protein-structure database management systems and structural data mining tools,” Jorge Leon, vice president of applied genomics at Quest Diagnostics, said in a statement.

“As the leader in gene-based testing, Quest Diagnostics has accumulated a large database of viral mutations.   Together, we can bring to bear advances in information technology to drive advances in patient care,” Leon said.

Quest Diagnostics and SBI formed a strategic alliance in July 1999 to work together to design and market database modules that contain thousands of protein structures. The database modules now contain thousands of forms of viral proteins. The data is derived from viral genotypes taken from patient specimens that have been analyzed by Quest Diagnostics.

Current Variome database modules offer more than 25,000 unique structures of two HIV-1 proteins, reverse transcriptase and protease. These modules give three-dimensional computer representations of the structures of all currently approved HIV-1 drugs docked to the active site of each archived protein.



The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.